Elevance Health, Inc.
NYSEElevance Health arrives at mid-week with its most constructive analyst backdrop in months — and a stock up 24% in a single month that is finally starting to earn its valuation lift. The catalyst shaping this week's note is the analyst desk. This morning, Deutsche Bank's George Hill upgraded ELV from Hold to Buy and lifted his price target from $363 to $498 — one of the…
ELV short interest jumps 26% in one week to 2.38% of float, driven by rising costs and analyst upgrades signaling strength in managed care.
Snapshot as of 20 May 2026
Elevance Health arrives at mid-week with its most constructive analyst backdrop in months — and a stock up 24% in a single month that is finally starting to earn its valuation lift. The catalyst shaping this week's…
Elevance Health heads into its May 13 earnings report on the back of a sharp 21% one-month rally and a wave of analyst optimism — leaving the debate squarely about whether the recovery in managed care valuations has…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ELV — free to start on ORTEX.
Sign up for free →Open ELV on ORTEX